Osiris Therapeutics, Inc. Reports Change In Tax Benefit Allocation For Fourth Quarter And Full Year 2013 Financial Results
Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today an accounting adjustment to its Fourth Quarter and Full Year 2013 financial results reported on March 5. The adjustment results from a change in the allocation of income tax benefits from continuing operations to discontinued operations. There is no change in net income, cash or cash flow.
Help employers find you! Check out all the jobs and post your resume.